Report from the American Society of Clinical Oncology (ASCO) with Dr. Carole Helissey
Drs. Carole Helissey and Charles Naltet from the Oncology Department attended ASCO 2026, the world’s premier cancer conference. This major annual event brings together international experts who help advance research and transform patient care.
At the conference, Dr. Carole Helissey shared the latest advances in the field of prostate cancer, with a focus on the cognitive impact of intensified therapy. This is a critical topic that underscores the importance of evaluating not only the effectiveness of treatments but also their impact on patients’ quality of life.
Every day, we continue our research efforts to identify the most relevant, effective, and appropriate treatments for each clinical situation.
Because innovation in medicine is, above all, about providing better care for patients !
